StockVS

The Clorox Company (CLX) 股票分析

防御性消费

The Clorox Company

$96.23

+$1.12 (+1.18%)

最后更新: 2026年5月26日

价格走势

最新新闻

新闻由第三方来源提供。不构成投资建议。

分析

公司概述

The Clorox Company manufactures and markets a diverse range of consumer and professional products globally, operating specifically within the Household & Personal Products industry under the Consumer Defensive sector. This sector classification indicates that the company's revenue streams are generally less sensitive to economic downturns compared to cyclical industries, providing a degree of stability often sought by capital allocators. The entity employs approximately 7,600 individuals and maintains a total market capitalization of $13.13 billion, reflecting its established position in the marketplace. With annual revenue reaching $6.76 billion, these financial metrics suggest the company operates at a significant scale, yet the market cap relative to revenue implies a valuation that does not necessarily command a large-cap premium over book value.

财务健康

The company reported a trailing twelve-month revenue of $6.76 billion and a net income of $755.00 million, while EBITDA stood at $1.23 billion. The substantial gap between revenue and net income reveals a cost structure where operating expenses, including taxes and interest, consume nearly 89% of gross revenue before arriving at the bottom line. Free cash flow is reported at $1.00 billion, which provides the organization with significant financial flexibility to fund capital expenditures, reduce leverage, or return capital to shareholders without immediate reliance on external financing. Gross margin stands at 44.2%, indicating strong pricing power or cost efficiency in production; operating margin is 14.0%, showing effective management of overheads; and profit margin is 11.2%, reflecting the final profitability after all expenses. Total cash on hand amounts to $227.00 million against total debt of $3.22 billion, resulting in a debt-to-equity ratio of 9191.43, which characterizes a highly leveraged balance sheet rather than a conservative one. The current ratio of 0.74 indicates that current assets fall short of current liabilities, suggesting potential short-term liquidity constraints that require careful working capital management. Return on equity is reported at an anomalous 987.2%, while return on assets is 11.3%, metrics that together reveal how management generates returns relative to shareholders' equity and total asset base, though the ROE figure warrants scrutiny regarding capitalization structure.

估值评估

The trailing twelve-month P/E ratio is 17.61, while the forward P/E is projected at 16.00, implying that the market expects earnings to expand in the coming year as analysts anticipate a lower multiple based on future performance. The price-to-book ratio is -104.08, a negative figure that indicates the market is pricing the stock at a significant discount relative to its book value, likely due to the high leverage or specific accounting adjustments affecting equity. The price-to-sales ratio stands at 1.94, and the EV/EBITDA multiple is 13.16, suggesting that investors are valuing the company based on earnings power and sales generation rather than just accounting book value. The 52-week high is $143.96 and the low is $96.66, meaning the current trading price sits somewhere within this historical range, subject to daily market fluctuations. The beta value is 0.65, which indicates that the stock's price volatility is lower than the broader market, suggesting it may act as a stabilizing component in a diversified portfolio.

Growth & Income

Revenue growth year-over-year is -0.8%, while earnings growth year-over-year is -16.2%, indicating that earnings are contracting at a significantly faster rate than revenue, which implies rising costs or pricing pressures are disproportionately affecting profitability. The company pays a dividend with a yield of 4.6%, and the payout ratio is 80.5%, meaning that a large portion of earnings is distributed to shareholders rather than retained for reinvestment. Given the high payout ratio combined with negative earnings growth, the sustainability of the dividend depends on whether operational improvements can reverse the earnings decline or if cash flow generation remains robust despite the drop in net income. Overall, the growth and income profile presents a scenario where income generation is currently facing headwinds, requiring management to navigate a period of earnings contraction while maintaining a substantial dividend yield.

同行比较

The Clorox Company (CLX) 在家庭与个人护理产品行业运营。以下是其与市值最接近的同行的比较:

公司 代码 市值 市盈率
The Clorox Company CLX $11.64B 15.7
The Procter & Gamble Company PG $336.34B 21.1
Unilever PLC UL $123.97B 19.0
Colgate-Palmolive Company CL $71.90B 34.8

家庭与个人护理产品行业平均市盈率为29.9倍。The Clorox Company的市盈率为15.7。

本分析由AI生成,仅供参考,不构成投资建议。数据可能存在延迟或不准确。在做出投资决策之前,请务必进行自己的研究并咨询合格的财务顾问。

关于The Clorox Company

The Clorox Company manufactures and markets consumer and professional products worldwide. The company operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers home care cleaning and disinfecting products, bleach, clog removers, and laundry additives under the Clorox, Clorox2, Pine-Sol, Scentiva, Tilex, Liquid-Plumr, Poett, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand in the United States. The Household segment provides cat litter products under the Fresh Step and Scoop Away brands; bags and wraps under the Glad brand; and grilling products under the Kingsford brand in the United States. The Lifestyle segment offers dressings, dips, seasonings, and sauces primarily under the Hidden Valley brand; water-filtration products under the Brita brand; and natural personal care products under the Burt's Bees brand in the United States. The International segment provides laundry additives, home care products, bags and wraps, cat litter products, water-filtration systems, professional cleaning and disinfecting products, natural personal care products, food, grilling products, and digestive health products internationally primarily under the Clorox, Glad, Poett, Brita, Burt's Bees, Pine-Sol, Ever Clean, Clorinda, Chux and Fresh Step Brands. It also offers vitamins, minerals, and supplement products under the Natural Vitality, RenewLife, NeoCell, and Rainbow Light brands. The company sells its products through mass retailers; grocery outlets; warehouse clubs; dollar stores; home hardware centers; drug, pet, and military stores; third-party and owned e-commerce channels; and distributors, as well as a direct sales force. The company was founded in 1913 and is headquartered in Oakland, California.

公司简介以英文显示。

访问官网 →

关键指标

市值
$11.64B
市盈率
15.65
52周最高
$132.03
52周最低
$84.70
平均成交量
2.73M
Beta系数
0.57
股息率
5.15%

数据由Yahoo Finance通过yfinance提供。每日更新。

公司信息

交易所
NYSE
国家
United States
员工数
7,600